HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Etienne Guillot Selected Research

Histamine H3 Antagonists

6/2013Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part II).
6/2013Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Etienne Guillot Research Topics

Disease

4Obesity
06/2013 - 04/2009
2Body Weight (Weight, Body)
10/2011 - 04/2009
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/2021
1Inflammation (Inflammations)
01/2021
1Cardiomyopathies (Cardiomyopathy)
01/2021
1Cardiovascular Diseases (Cardiovascular Disease)
06/2020
1Respiratory Tract Diseases (Respiratory Tract Disease)
02/2019
1Dyslipidemias (Dyslipidemia)
04/2009
1Insulin Resistance
04/2009

Drug/Important Bio-Agent (IBA)

2Glucose (Dextrose)FDA LinkGeneric
01/2021 - 04/2009
2AmidesIBA
06/2013 - 06/2013
2Histamine H3 AntagonistsIBA
06/2013 - 06/2013
2AdiponectinIBA
10/2011 - 04/2009
2RimonabantIBA
10/2011 - 04/2009
1ApelinIBA
01/2021
1Lipoprotein(a)IBA
06/2020
1AntibodiesIBA
02/2019
1CannabinoidsIBA
10/2011
1CB1 Cannabinoid Receptor (CB1 Receptor)IBA
10/2011
1CholesterolIBA
10/2011
1Insulin (Novolin)FDA Link
10/2011
1Triglycerides (Triacylglycerol)IBA
10/2011
1LeptinIBA
10/2011
1Messenger RNA (mRNA)IBA
04/2009